Identification of a PANoptosis-related gene signature reveals therapeutic potential of SFRP2 in pulmonary arterial hypertension
SFRP2 was identified as a potential biomarker for PAH, impacting cell proliferation and resistance to apoptosis, thus providing new insights for PAH prevention and treatment.
Authors
- Mukamengjiang Juaiti (ORCID: https://orcid.org/0000-0003-0714-4392)
- Li Li (ORCID: https://orcid.org/0000-0003-2459-3499)
Institutions
- Fourth Hospital of Changsha (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-04-29
- DOI
- https://doi.org/10.3389/fcvm.2025.1521087
- Citations
- 2
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.04